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Abstract: 
Medullary Sponge Kidney (MSK) is a benign disorder associated with renal stones in 
60% of patients.  Patients frequently have episodic painless hematuria but are otherwise 
asymptomatic unless renal calculi or infections complicate the disease.  Nephrolithiasis is a 
relative, but frequently enforced, contraindication to space or other high performance flight.  
Two case reports of asymptomatic NASA flight crew with MSK and three cases of military 
aviators diagnosed with MSK are reviewed, all cases resulted in waiver and return to flight status 
after treatment and a vigorous follow up and prophylaxis protocol.  MSK in aviation and space 
flight necessitates a highly case-by-case dependent evaluation and treatment process to rule out 
other potential confounding factors that might also contribute to stone formation and in order to 
re-qualify the aviator for flight duties. 
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Introduction: 
 
The United States military and NASA maintain medical standards for aviation. The 
purpose of these standards is to identify diseases that pose a significant risk in the often harsh 
and uncompromising aerospace environments.  The medical standards are not static; and are 
subject to change as aeromedical research allows more informative risk management.  We 
review two case reports of NASA aviators with medullary sponge kidney.  We will discuss this 
condition, specifically exploring its predilection to predispose these individuals to renal stones.  
Also addressed are the subsequent aeromedical disposition and suggestions as to what screening, 
testing, and precautions should be taken in the future.   
Medullary sponge kidney (MSK) is a benign cystic disorder characterized by diffuse 
cystic dilatation of the collecting ducts limited to the renal medulla.  Lenarduzzi first described 
dilatation of the renal pyramids by excretory urography in 1939 (15).  A decade later Cachii and 
Ricci classified and described MSK as a disease, resulting in MSK’s eponym Cachii-Ricci 
Disease or its other synonym Tubular Ectasia (2).  The incidence of MSK varies from 1 in 5000 
to 1 in 20,000 in the general population (10,27) and from 1 in 200 to 1 in 20,000 of all excretory 
urograms (18,23,27). This condition is generally discovered in patients in their third to sixth 
decade (6). It is more common in men and Caucasians but has a higher rate of complications 
from calculi in women (1,5,27).  The pathogenesis of MSK remains unknown but most authors 
agree it represents a developmental defect of the collecting tubules (6,27).  Diagnosis of this 
condition is most commonly made by intravenous pyelogram (IVP) which shows collections of 
contrast adjacent to calices with varying degrees of enhanced pyramidal blush (27) (a.k.a. “paint-
brush,” “fan-shaped,” “bunches of flowers,” “cluster of grapes,” “mosaic pattern” or 
“puddling”).  Ekstrom reviewed 44 cases of MSK and found the urogram to be 
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“roentgenologically pathonomonic” in all but one (5). Pyrah has classified this disease into three 
groups:  1) patients who were asymptomatic but had diagnostic findings by IVP, 2) patients with 
nephrocalcinosis and symptoms and 3) patients with frank renal calculi and symptoms (25).  The 
disease is generally pan renal and bilateral (75% bilateral).  Case reports of segmental MSK are 
uncommon in the literature (1,5,7,9,19,23).  
MSK is usually asymptomatic and discovered when an infection or stones complicate the 
condition.  As a rule MSK does not grossly impair renal function (6,25,27). The most common 
chief complaints include hematuria (10% -55%), renal colic (11%-60%), lumbar pain (33%), 
pyuria (18%), chronic pyelonephritis (5%-16%) and urinary symptoms (11%-33%) (1,5,6). 
Approximately two thirds of patients with MSK also have impaired medullary concentrating 
ability with polyuria (6,27). Type I absorptive hypercalciuria has been a well documented but 
poorly understood association with MSK (7,27). Much more rarely, Renal Tubular Acidosis 
Type II has been associated with MSK (27). 
Renal stone incidence in MSK is controversial as non-stone forming individuals are less 
likely to undergo excretory urograms.  The reported range of stone formation has varied from 
40%-94% of those incidentally radiographically diagnosed with MSK (1,5,16,17).  Lifetime 
morbidity of 60% is the most commonly quoted number, with 50% being symptomatic within 
five years of diagnosis.  These calculi most commonly are due to a combination of urinary stasis 
within the dilated collecting tubules (1) and additional metabolic or structural abnormalities (8). 
Ten percent of those with symptomatic MSK have a poor renal function prognosis due to 
intractable stones and UTIs (27). 
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Aeromedical Case Histories: 
The first case is a male NASA flight crew member who presented with asymptomatic 
microscopic hematuria on routine annual flight physical examination.   IVP was performed, 
which showed no evidence of calculi, but was consistent with classic findings for the renal 
tubule ectasia of MSK (Figure 1).  A renal stone risk profile (RSRP) was obtained.  A total of 
2.65 liters of urine over a 24 hour period revealed 1,778 mg of creatinine (indicative of a full 24 
hour collection), calcium 120 mg, oxalate 30.1 mg, uric acid 530 mg, pH 5.6, sodium 109 mEq, 
sulfate 20.4 mmol, phosphate 1092 mg.  All parameters were within normal limits, however the 
pH and phosphate limits were at the upper limit of normal.  The relative supersaturation for 
calcium oxalate, brushite, sodium urate, uric acid and magnesium-ammonia-phosphate were all 
within normal range.  Citrate and magnesium (600 mg and 87 mg respectively) were both in 
normal inhibitory concentrations.  The overall conclusions from RSRP deemed the patient to be 
at no increased metabolic risk for stone formation.   
Due to the absence of findings of metabolic stone risk factors, the patient received a 
waiver for short duration space flight assignments, but due to the natural history of MSK the 
patient was not waived for long duration flight assignments (defined as greater than 30 days), 
such as those on the International Space Station.  Annual follow up with RSRP and imaging was 
also required.  The patient has been asymptomatic and without calculi to the present. 
 
In the second case a NASA pilot presented with episodic painless hematuria and pyuria 
with 1+ calcium oxalate crystals on urinalysis.  Nephrotomograms with pyelogram revealed an 
8mm calcification in the upper pole of the left kidney and a 3mm calculus in the lower pole of 
the right kidney.  The patient was disqualified from flight. 
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The patient underwent two courses of bilateral treatment with extracorporeal shock wave 
lithotripsy.  Post treatment renal tomography revealed residual calcification in the left upper 
pole, which was felt to be within the parenchyma of the kidney in the ectatic tubules of a 
segmental form of medullary sponge kidney.  The remaining kidney had normal tubular 
structure.  These conclusions were validated by a left retrograde pyelography concomitant with a 
fine cut, non-contrast CT scan.   
A metabolic stone evaluation revealed normal serum electrolytes, calcium, and uric acid 
levels.  Two of three 24-hour urine collections revealed mildly elevated urine calcium at 366 mg 
(normal <250mg) and one increased uric acid level giving a slightly increased risk on RSRP.  
The aviator was felt to have an incomplete variant of Type I absorptive hypercalcuria producing 
the minimal elevation in urinary calcium without supersaturation. 
A NASA Aeromedical Board voted, based on the removal of calcification from the 
collecting system, to return the patient to full flight status (as primary pilot) in dual piloted 
aircraft.  There was no restriction on calcium intake but aggressive hydration was deemed 
mandatory, as well as close follow-up of urinalysis, serum chemistries, 24 hour urine collections, 
a plain abdominal radiograph (KUB) every 3 months, and a renal ultrasound or excretory 
urogram with tomograms every 6 months.  Any progression of calcification, worsening 
pyuria/hematuria or increase in RSRP or calcium oxalate saturation index would have called for 
re-evaluation with possible disqualification from primary pilot status, or additional required 
intervention (e.g. thiazide diuretics, dietary restrictions, or inhibitor supplements).  
Follow-up interval evaluations have shown no genitourinary symptoms, no pyuria, no 
worsening of microhematuria, and no progression of the calcifications on imaging.  His serum 
creatinine is normal at 0.7mg/dL, as well as a serum uric acid of 5.5 mg/dL and calcium of 9.2 
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mg/dL.  The patient is currently on a low animal protein diet, has increased his oral hydration, 
and avoids any periods of prolonged heat exposure on take off or landing that might predispose 
to dehydration.  
Three additional cases (7,9,19) were found in the literature of USAF aviators, all with a 
segmental form of MSK.  Two of the three received a segmental nephrectomy. The third had a 
radical nephrectomy as IVP, US, and CT all indicated a space-occupying lesion without 
calcification. This lesion on pathologic examination revealed unilateral matrix material in ectatic 
tubules consistent with segmental MSK.  Unlike the NASA case reports, which were 
asymptomatic, all of these patients presented with flank pain, one had a past medical history 
significant for pyelonephritis and the other had multiple UTIs and stones.  Post surgery all of 
these individuals were able to return to full flight status within one year.
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Discussion: 
The extreme environments of high performance aviation and space travel, combined with 
the grave consequences of medical emergencies in these environments, requires the DOD, FAA, 
and NASA to have strict medical standards for pilots.  The decision to waiver disqualifying 
medical conditions is a balance between the potential risks of a medical emergency with the loss 
of service of a highly trained pilot.  If MSK were suspected on initial screening of an astronaut 
candidate, and MSK was confirmed on IVP, it would be disqualifying. The development of 
urinary calculi in DOD or NASA pilots, who have been previously screened for stone disease 
prior to selection, is felt to be in most cases environmentally-induced.  Screened individuals are 
not at the same risk level as the general population due to the vigorous selection process.  
However, due to the sporadic nature and variable presentation of MSK, these patients were not 
detected on screening ultrasound.  Therefore, their occupational environment would only 
partially contribute to the development of their calculi. 
In the space environment, this risk of calculi formation is increased both in- and post-
flight by multiple metabolic factors (28,29).  Osteoclastic activity is dramatically increased and 
grossly results in a one to one and a half percent loss of bone mass per month (11,13). In 
comparison, a severely osteoporotic postmenopausal woman loses that same amount in one year 
(11,13). This results in the hypercalciuria of microgravity.  Additionally, hypocitraturia, low 
urine pH, a 10%-15% decrease in plasma volume and lower urine volume (12,28,29) resulting 
from the microgravity environment also predispose to stone formation. This has resulted in one 
in-flight urinary calculus and more then ten post-flight calculi in the combined Russian and US 
space flight experience.   
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On the other hand, the USAF and US Navy (USN) have extensive experience with renal calculi 
in aviators.  In the USAF the history of a single uncomplicated renal calculus is not medically 
disqualifying for flight, and persons with a history of multiple stones may even be returned to 
flying duty (4).  USN aviators with a history of an uncomplicated renal stone must wait 12 weeks 
before returning to flying status, after suitable therapy (20).  These approaches seem to be 
justified as a review of naval aviators revealed a reoccurrence rate of only 2% after a single stone 
(26) verses 33%+ expected in the general population and 75% reoccurrence if untreated.  
However, often these pilots are removed from USAF Class I, or USN Service Group 1 or 2 
statuses, and restricted to multipiloted, non-high performance aircraft, where the risk from acute 
renal/ureteral colic would be much less devastating.  The standards affecting aviator and crew 
qualification status (4, 20) do not allow renal anomalies or diseases that produce significant renal 
dysfunction or urinary calculi, so these conditions require waiver on a case-by-case basis. 
           
Because of the relative rarity of MSK, experience with this condition within the aerospace 
medicine community is limited.  However, there is a growing body of evidence that indicates the 
majority of aviators with MSK can continue their flying duties with acceptable risk.  From 1987 
to 2000, nine naval and marine aviators were found to have MSK (20). Six received waivers 
(five presented with renal stones and one with recurrent hematuria); none of the six have had 
subsequent complications due to MSK.  Three aviators were denied waivers due to retained or 
recurrent stones.  From 1970 to 2000 the USAF has granted waivers to 29 aviators with MSK. 
Two were later permanently disqualified for recurrent calculi (4). 
Hsu et al’s research suggests that “physiologic environment of the urine” resulting in 
urinary stasis is alone unlikely to cause stone formation but usually must be superimposed on 
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other metabolic or physiologic abnormalities (8). Some of these metabolic abnormalities are 
induced in a microgravity environment, and the question still remains if these microgravity 
changes are sufficient to cause stone formation in those with MSK, or if a third factor is needed. 
An association between MSK and hypercalciuria has been reported as far back as 1959 
by Ekstrom (5). O’Neill in his series of 17 cases found that 59% of patients with MSK also had 
absorptive hypercalciuria (21).  The abnormality in absorptive hypercalciuria is excess small 
intestinal calcium absorption, which leads to an increase in urine calcium (22,24). The exact 
pathogenic mechanism for the enhanced absorption remains unknown.  In the majority of 
patients with this disorder, absorption of calcium is independent of vitamin D concentration (14). 
This disorder can be treated with sodium cellulose phosphate (24). 
In conclusion, we have multiple NASA and DOD aviators diagnosed with MSK, a 
condition well known to increase urinary stone and infection risk.  Space flight has additional 
microgravity risk factors pre-disposing to stones.  Evaluation of these individuals on a case-by-
case level should weigh the extent of the MSK (i.e. segmental vs. pan renal/bilateral disease), 
metabolic abnormalities (e.g. hypercalciuria), structural abnormalities (e.g. diverticuli), and past 
symptoms (prior stones, infections, extensive hematuria, etc).  The majority of patients with 
MSK will develop stones or infection, but urinary stasis in and of itself may not be sufficient to 
be the only etiology.  Depending on secondary predisposing factors there may be a need to 
intervene by: altering diet (e.g. decreased oxalate or uric acid containing foods such as red meat, 
decreased sodium intake), increasing hydration (>2 liters per day minimum), avoiding excessive 
mineral supplements, decreasing caffeine intake, and pharmaceutical therapy (e.g. thiazide 
diuretics, sodium cellulose phosphate).  MSK aviators, if waived for flight duty, must have close 
follow up with frequent RSRP analysis, imaging, and monitoring for other signs and symptoms 
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of pathology.  If stones occur, the patient should be restricted from flight until treatment renders 
the collecting system free of stones, realizing that calcification may persist in the parenchyma, 
which is not necessarily disqualifying.  Partial nephrectomy to remove the severely affected 
regions of segmental MSK (3) have as presented above resulted in return to flight status in less 
than twelve months.  Surgical treatment is not indicated for the mere presence of stones in the 
general population (3).  In the aerospace community, however, if prompt return to flight status is 
deemed necessary than surgery may be the most expeditious means of qualifying the aviator for 
waiver.  The risk of partial nephrectomy in the case of segmental MSK must be carefully 
considered on a case-by-case basis. 
 
Legend to figures: 
Figure 1.  IVP showing characteristic bilateral dilated tubules of MSK with contrast blush 
extending from calices. 
Figure 2.    CT depicting calculi of MSK in the right kidney parenchyma. 
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